CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 59 filers reported holding CORVUS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $281,059 | -12.1% | 192,506 | +37.9% | 0.00% | – |
| Q2 2023 | $319,764 | +250.8% | 139,635 | +39.4% | 0.00% | – |
| Q1 2023 | $91,145 | +47.7% | 100,159 | +38.0% | 0.00% | – |
| Q4 2022 | $61,714 | +92.9% | 72,605 | +84.7% | 0.00% | – |
| Q3 2022 | $32,000 | -34.7% | 39,317 | -20.3% | 0.00% | – |
| Q2 2022 | $49,000 | -26.9% | 49,348 | +20.8% | 0.00% | – |
| Q1 2022 | $67,000 | -23.9% | 40,862 | +10.8% | 0.00% | – |
| Q4 2021 | $88,000 | -39.3% | 36,876 | +23.2% | 0.00% | – |
| Q3 2021 | $145,000 | +46.5% | 29,943 | -19.3% | 0.00% | – |
| Q2 2021 | $99,000 | -13.9% | 37,124 | -0.3% | 0.00% | – |
| Q1 2021 | $115,000 | -14.8% | 37,253 | -1.8% | 0.00% | – |
| Q4 2020 | $135,000 | +3.1% | 37,943 | +15.9% | 0.00% | – |
| Q3 2020 | $131,000 | +219.5% | 32,746 | +117.7% | 0.00% | – |
| Q2 2020 | $41,000 | -40.6% | 15,042 | -54.3% | 0.00% | – |
| Q1 2020 | $69,000 | -67.1% | 32,920 | -14.8% | 0.00% | – |
| Q4 2019 | $210,000 | +54.4% | 38,628 | -14.9% | 0.00% | – |
| Q3 2019 | $136,000 | +11.5% | 45,372 | +39.0% | 0.00% | – |
| Q2 2019 | $122,000 | -47.0% | 32,631 | -43.1% | 0.00% | – |
| Q1 2019 | $230,000 | +82.5% | 57,299 | +67.6% | 0.00% | – |
| Q4 2018 | $126,000 | -38.2% | 34,186 | +43.7% | 0.00% | – |
| Q3 2018 | $204,000 | -40.0% | 23,792 | -23.2% | 0.00% | – |
| Q2 2018 | $340,000 | +21.0% | 30,969 | +27.2% | 0.00% | – |
| Q1 2018 | $281,000 | +50.3% | 24,348 | +34.7% | 0.00% | – |
| Q4 2017 | $187,000 | -17.3% | 18,073 | +27.9% | 0.00% | – |
| Q3 2017 | $226,000 | +107.3% | 14,136 | +58.5% | 0.00% | – |
| Q2 2017 | $109,000 | -44.4% | 8,920 | -5.4% | 0.00% | – |
| Q1 2017 | $196,000 | -31.0% | 9,430 | -52.7% | 0.00% | – |
| Q4 2016 | $284,000 | +1793.3% | 19,942 | +2096.3% | 0.00% | – |
| Q3 2016 | $15,000 | +400.0% | 908 | +314.6% | 0.00% | – |
| Q1 2016 | $3,000 | – | 219 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 3,275,616 | $8,746,000 | 1.82% |
| Telemetry Investments, L.L.C. | 263,975 | $705,000 | 0.97% |
| CHI Advisors LLC | 719,132 | $1,920,000 | 0.45% |
| BVF INC/IL | 3,678,626 | $9,822,000 | 0.37% |
| EcoR1 Capital, LLC | 3,579,377 | $9,557,000 | 0.36% |
| Orbimed Advisors | 8,053,298 | $21,502,000 | 0.22% |
| Stonepine Capital Management, LLC | 46,886 | $125,000 | 0.06% |
| Ikarian Capital, LLC | 100,000 | $267,000 | 0.02% |
| ALGERT GLOBAL LLC | 19,737 | $53,000 | 0.02% |
| Windsor Creek Advisors, LLC | 14,786 | $39,000 | 0.01% |